Tigress Financial initiates Oklo stock coverage with buy rating By Investing.com

Tigress Financial initiated coverage on Oklo with a $130 price target versus the current $71 stock price, implying substantial upside, though analyst targets remain highly dispersed from $14 to $168. The note highlighted Oklo’s Aurora sodium-cooled fast reactor, HALEU fuel cycle, Power-as-a-Service model, and partnerships in data centers, AI, National Labs, and isotope production as key growth drivers. Offsetting the bullish view, analysts still do not expect profitability this year, and the stock has already surged 199% over the past year.

Analysis

Oklo is increasingly trading like an option on regulatory and infrastructure optionality rather than a utility buildout story. The real second-order winner is not just the reactor developer but the adjacent ecosystem: HALEU enrichment, fuel validation, power electronics, and AI/data-center infrastructure suppliers that can monetize pre-commercial spend long before first revenue. NVIDIA's involvement matters less as a direct commercial catalyst and more as a credibility signal that can compress the financing discount for compute-adjacent nuclear projects; that helps the entire advanced-nuclear basket, even if fundamentals remain years away.

The stock is vulnerable to the classic pre-revenue trap: multiple expansion can outrun execution, but any schedule slip can cut the narrative in half because the equity value is still dominated by terminal assumptions. The biggest near-term catalyst is not reactor delivery but permitting and DOE program milestones over the next 3-9 months; conversely, a broader risk-off tape or higher real rates would hit duration-heavy names like OKLO disproportionately. UBS's more cautious view is important because it frames where the market can de-rate this quickly: if capex intensity or fuel-cycle complexity proves harder than expected, the stock can retrace sharply even without any fundamental failure.

The contrarian angle is that consensus is treating strategic partnerships as de-risking, when they may actually increase the probability of a slow, expensive commercialization path. If management uses these partnerships to raise at elevated valuations, existing holders benefit, but future equity dilution becomes the hidden tax on the story. In that sense, the best risk/reward may be in the suppliers and enablers that get paid on milestones, not the company shouldering the full technology and financing risk.

For the broader group, advanced nuclear becomes a relative beneficiary if energy-security and AI-power scarcity stay in focus, but the trade is vulnerable if oil/energy headlines fade and investors rotate back to near-term cash generators. The market is likely underpricing how much of the move is driven by scarcity of credible clean baseload narratives rather than near-term earnings power; that means momentum can persist, but only as long as capital markets remain open and supportive.

Key Decisions for Investors

• Tactically long OKLO on pullbacks over the next 1-3 weeks, but size it as a high-beta momentum trade, not a valuation anchor; use a 15-20% stop because any execution slip or risk-off tape can compress the multiple fast.
• Pair trade: long OKLO / short a higher-quality cash-yielding utility or industrial with nuclear exposure over 1-3 months; the thesis is that OKLO benefits most from narrative beta, but the short leg cushions a de-rating event if rates rise.
• Prefer the picks-and-shovels exposure: long NVDA on any weakness as a beneficiary of AI-power infrastructure linkage over 3-6 months; the asymmetric upside is that nuclear adjacency reinforces the compute buildout story without reactor execution risk.
• Consider a basket long in advanced nuclear enablers versus a direct short in the most stretched pre-revenue nuclear equity if available; the goal is to own milestone-paid cash flow rather than binary commercialization risk.
• Avoid chasing OKLO after sharp gap-ups; instead, buy only on post-news consolidation or after a failed breakout, because the stock’s path dependency is likely to be driven by financing and permitting headlines rather than operating fundamentals.